GL1X · GenesisL1 explorer

MolNFT v2 · #226548 · protein

Crystal structure of MERS 3CL protease in complex with a racemic bicyclo[2.2.1]heptenyl-methyl 2-pyrrolidone inhibitor

9ATI · 3C-like proteinase nsp5: “Crystal structure of MERS 3CL protease in complex with a racemic bicyclo[2.2.1]heptenyl-methyl 2-pyrrolidone…”. X-ray diffraction at 1.6, 2 ligands (A1AGV, A1AGU), 2 pockets (best druggability 0.52). MolNFT…

PDB
9ATI
Type
protein
Length
305 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
1.6
Source
Middle East respiratory syndrome-related coronavirus
Molecule
3C-like proteinase nsp5
EC
3.4.22.69
UniProt
K9N638
Ligands
A1AGV, A1AGU
Pockets
2 · best druggability 0.52

Structure

x-ray diffraction · resolution 1.6 · 1 distinct chain · 23% helix, 29% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A3C-like proteinase nsp5 (EC 3.4.22.69)protein30523% helix, 29% strandK9N638

Ligands and binding sites

  • A1AGV · (1S,2S)-2-{[N-({[(3S)-1-{[(1R,2R,4R)-bicyclo[2.2.1]hept-5-en-2-yl]methyl}-5-oxopyrrolidin-3-yl]methoxy}carbonyl)-L-leucyl]amino}-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid · ligand · chains A
  • A1AGU · (1R,2S)-2-{[N-({[(3S)-1-{[(1R,2R,4R)-bicyclo[2.2.1]hept-5-en-2-yl]methyl}-5-oxopyrrolidin-3-yl]methoxy}carbonyl)-L-leucyl]amino}-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12400.520.7644empty
22080.520.7727A1AGV, A1AGU

Modifications

Observed in the structure: 2 covalent (covalent ligand).

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.